252 related articles for article (PubMed ID: 37930837)
1. INTEDE 2.0: the metabolic roadmap of drugs.
Zhang Y; Liu X; Li F; Yin J; Yang H; Li X; Liu X; Chai X; Niu T; Zeng S; Jia Q; Zhu F
Nucleic Acids Res; 2024 Jan; 52(D1):D1355-D1364. PubMed ID: 37930837
[TBL] [Abstract][Full Text] [Related]
2. INTEDE: interactome of drug-metabolizing enzymes.
Yin J; Li F; Zhou Y; Mou M; Lu Y; Chen K; Xue J; Luo Y; Fu J; He X; Gao J; Zeng S; Yu L; Zhu F
Nucleic Acids Res; 2021 Jan; 49(D1):D1233-D1243. PubMed ID: 33045737
[TBL] [Abstract][Full Text] [Related]
3. DrugMAP: molecular atlas and pharma-information of all drugs.
Li F; Yin J; Lu M; Mou M; Li Z; Zeng Z; Tan Y; Wang S; Chu X; Dai H; Hou T; Zeng S; Chen Y; Zhu F
Nucleic Acids Res; 2023 Jan; 51(D1):D1288-D1299. PubMed ID: 36243961
[TBL] [Abstract][Full Text] [Related]
4. DrugBank 4.0: shedding new light on drug metabolism.
Law V; Knox C; Djoumbou Y; Jewison T; Guo AC; Liu Y; Maciejewski A; Arndt D; Wilson M; Neveu V; Tang A; Gabriel G; Ly C; Adamjee S; Dame ZT; Han B; Zhou Y; Wishart DS
Nucleic Acids Res; 2014 Jan; 42(Database issue):D1091-7. PubMed ID: 24203711
[TBL] [Abstract][Full Text] [Related]
5. The pharmacogenetics of drug metabolizing enzymes in the Lebanese population.
Ossaily S; Zgheib NK
Drug Metabol Drug Interact; 2014; 29(2):81-90. PubMed ID: 24413215
[TBL] [Abstract][Full Text] [Related]
6. VARIDT 3.0: the phenotypic and regulatory variability of drug transporter.
Yin J; Chen Z; You N; Li F; Zhang H; Xue J; Ma H; Zhao Q; Yu L; Zeng S; Zhu F
Nucleic Acids Res; 2024 Jan; 52(D1):D1490-D1502. PubMed ID: 37819041
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of pharmacokinetic studies on herbal drug Fuzi: Implications for Fuzi as personalized medicine.
Wu JJ; Guo ZZ; Zhu YF; Huang ZJ; Gong X; Li YH; Son WJ; Li XY; Lou YM; Zhu LJ; Lu LL; Liu ZQ; Liu L
Phytomedicine; 2018 May; 44():187-203. PubMed ID: 29526584
[TBL] [Abstract][Full Text] [Related]
8. High-Throughput Assessment of Metabolism-Induced Toxicity of Compounds on a 384-Pillar Plate.
Kang SY; Yu KN; Joshi P; Lee MY
Methods Mol Biol; 2020; 2089():191-207. PubMed ID: 31773656
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.
Rushmore TH; Kong AN
Curr Drug Metab; 2002 Oct; 3(5):481-90. PubMed ID: 12369894
[TBL] [Abstract][Full Text] [Related]
10. The evolving role of drug metabolism in drug discovery and development.
Yengi LG; Leung L; Kao J
Pharm Res; 2007 May; 24(5):842-58. PubMed ID: 17333392
[TBL] [Abstract][Full Text] [Related]
11. Advances in drug metabolism and pharmacogenetics research in Australia.
Mackenzie PI; Somogyi AA; Miners JO
Pharmacol Res; 2017 Feb; 116():7-19. PubMed ID: 27956261
[TBL] [Abstract][Full Text] [Related]
12. DRESIS: the first comprehensive landscape of drug resistance information.
Sun X; Zhang Y; Li H; Zhou Y; Shi S; Chen Z; He X; Zhang H; Li F; Yin J; Mou M; Wang Y; Qiu Y; Zhu F
Nucleic Acids Res; 2023 Jan; 51(D1):D1263-D1275. PubMed ID: 36243960
[TBL] [Abstract][Full Text] [Related]
13. Clinically relevant genetic variations in drug metabolizing enzymes.
Pinto N; Dolan ME
Curr Drug Metab; 2011 Jun; 12(5):487-97. PubMed ID: 21453273
[TBL] [Abstract][Full Text] [Related]
14. Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it.
Verma H; Singh Bahia M; Choudhary S; Kumar Singh P; Silakari O
Drug Metab Rev; 2019 May; 51(2):196-223. PubMed ID: 31203662
[TBL] [Abstract][Full Text] [Related]
15. A mapping of drug space from the viewpoint of small molecule metabolism.
Adams JC; Keiser MJ; Basuino L; Chambers HF; Lee DS; Wiest OG; Babbitt PC
PLoS Comput Biol; 2009 Aug; 5(8):e1000474. PubMed ID: 19701464
[TBL] [Abstract][Full Text] [Related]
16. BioM2MetDisease: a manually curated database for associations between microRNAs, metabolites, small molecules and metabolic diseases.
Xu Y; Yang H; Wu T; Dong Q; Sun Z; Shang D; Li F; Xu Y; Su F; Liu S; Zhang Y; Li X
Database (Oxford); 2017 Jan; 2017():. PubMed ID: 28605773
[TBL] [Abstract][Full Text] [Related]
17. Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates.
Jónsdóttir SO; Jørgensen FS; Brunak S
Bioinformatics; 2005 May; 21(10):2145-60. PubMed ID: 15713739
[TBL] [Abstract][Full Text] [Related]
18. NPCDR: natural product-based drug combination and its disease-specific molecular regulation.
Sun X; Zhang Y; Zhou Y; Lian X; Yan L; Pan T; Jin T; Xie H; Liang Z; Qiu W; Wang J; Li Z; Zhu F; Sui X
Nucleic Acids Res; 2022 Jan; 50(D1):D1324-D1333. PubMed ID: 34664659
[TBL] [Abstract][Full Text] [Related]
19. General theory for multiple input-output perturbations in complex molecular systems. 1. Linear QSPR electronegativity models in physical, organic, and medicinal chemistry.
González-Díaz H; Arrasate S; Gómez-SanJuan A; Sotomayor N; Lete E; Besada-Porto L; Ruso JM
Curr Top Med Chem; 2013; 13(14):1713-41. PubMed ID: 23889050
[TBL] [Abstract][Full Text] [Related]
20. Feature, Function, and Information of Drug Transporter-Related Databases.
Yin J; Li F; Li Z; Yu L; Zhu F; Zeng S
Drug Metab Dispos; 2022 Jan; 50(1):76-85. PubMed ID: 34426411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
